58048-25-2 Usage
Uses
Used in Pharmaceutical Industry:
(2S,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-N-(cyclopropylmethyl)-3,4-dihydroxytetrahydrofuran-2-carboxamide (non-preferred name) is used as a potential candidate for the development of new antiviral and anticancer drugs due to its structural similarity to nucleoside analogs, which are known for their therapeutic effects in these areas.
Used in Research and Development:
In the field of medicinal chemistry, (2S,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-N-(cyclopropylmethyl)-3,4-dihydroxytetrahydrofuran-2-carboxamide (non-preferred name) serves as a subject for research and development to explore its potential as a lead compound for the creation of novel therapeutic agents. Its unique structure may offer new avenues for targeting viral and cancerous processes, pending further investigation into its pharmacological properties and mechanisms of action.
Check Digit Verification of cas no
The CAS Registry Mumber 58048-25-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,8,0,4 and 8 respectively; the second part has 2 digits, 2 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 58048-25:
(7*5)+(6*8)+(5*0)+(4*4)+(3*8)+(2*2)+(1*5)=132
132 % 10 = 2
So 58048-25-2 is a valid CAS Registry Number.
58048-25-2Relevant academic research and scientific papers
Modification of the 5' Position of Purine Nucleosides. 2. Synthesis and Some Cardiovascular Properties of Adenosine-5'-(N-substituted)carboxamides
Prasad, Raj Nandan,Bariana, Dilbagh S.,Fung, Anthony,Savic, Milica,Tietje, Karin,et al.
, p. 313 - 319 (2007/10/02)
We have shown previously that the esters of adenosine-5'-carboxylic acid (10) represent a new class of potent nontoxic coronary vasodilators.For example, the ethyl ester (12), which is active by an intraduodenal or intravenous route in dogs, causes a larg
Adenosine-5'-carboxylic acid amides
-
, (2008/06/13)
Adenosine-5'-carboxylic acid amides represented by the formula STR1 wherein R1 and R2 are each selected from the group consisting of hydrogen, loweralkyl, lowerhaloalkyl, lowerhydroxyalkyl, lowercycloalkyl, loweralkylcycloalkyl, loweralkenyl, lowerhaloalkenyl, lowerhydroxyalkenyl, loweralkynyl, lowerhaloalkynyl, benzylamino, phenyl, loweralkylphenyl, loweralkoxyloweralkyl, substituted phenyl, 2-methylfuran or di(C1 -C4)alkylamino(C1 -C4)alkyl, adamantyl or R1 and R2 taken together form a 5 or 6 membered heterocyclic moiety; R3 and R4 are hydrogen or acyl, or taken together form an isopropylidene or a benzylidene group; or a pharmaceutically acceptable acid addition salt thereof.
